Two Pfizer and BioNTech Covid-19 vaccine boosters updated to target the Omicron variant show a substantially higher immune response than the current Covid-19 vaccine.
The companies tested a vaccine that targets Omicron BA.1 subvariant and bivalent booster -- which targets two strains -- that includes the current Pfizer/BioNTech Covid-19 vaccine and a vaccine candidate that targets Omicron.New coronavirus subvariants escape antibodies from vaccination and prior Omicron infection, studies suggestThe study looked at two different dose levels -- 30 micrograms and 60 micrograms -- in more than 1,200 adults age 56 and older.
"Based on these data, we believe we have two very strong Omicron-modified candidates that elicit a substantially higher immune response against Omicron than we've seen to date," Pfizer Chairman and Chief Executive Officer Albert Bourla said in a news release.Earlier this month, Moderna reported its bivalent Covid-19 vaccine booster that contained a vaccine targeting Omicron showed a stronger immune response against the variant.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer says tweaked Covid-19 shots boost omicron protectionThe announcement comes days before an FDA advisory committee meeting to discuss whether to offer updated boosters to Americans this fall.
Lire la suite »
Pfizer Says Tweaked COVID-19 Shots Boost Omicron ProtectionPfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection.
Lire la suite »
Pfizer says tweaked COVID-19 shots boost omicron protectionPfizer says either an omicron-targeted booster or a combination shot that mixes the original vaccine with omicron protection substantially increases protection.
Lire la suite »
Pfizer says tweaked COVID-19 shots boost omicron protectionPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer Americans updated booster shots this fall.
Lire la suite »
Moderna COVID-19 shots now an option for older kids in U.S.The CDC now recommends Moderna's COVID-19 shots as an option for school-age kids and teens.
Lire la suite »
Sulzbacher Village hosts COVID-19 vaccination event for children as young as 6 monthsSulzbacher is one of the few places to get the vaccines almost immediately because it is a part of a federal network of free or low-cost clinics.
Lire la suite »